Article Versions Notes

Komori R, Takamura Y, Yamada Y, Morioka M, Matsubara H, Hirano T, Mitamura Y, Shimizu M, Kusuhara S, Murakami T, et al. Impact of the COVID-19 Pandemic on Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Japan. Journal of Clinical Medicine. 2022; 11(22):6794. https://doi.org/10.3390/jcm11226794

Komori, Ryohei, Yoshihiro Takamura, Yutaka Yamada, Masakazu Morioka, Hisashi Matsubara, Takao Hirano, Yoshinori Mitamura, Miho Shimizu, Sentaro Kusuhara, Tomoya Murakami, and et al. 2022. "Impact of the COVID-19 Pandemic on Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Japan" Journal of Clinical Medicine 11, no. 22: 6794. https://doi.org/10.3390/jcm11226794

Komori, R., Takamura, Y., Yamada, Y., Morioka, M., Matsubara, H., Hirano, T., Mitamura, Y., Shimizu, M., Kusuhara, S., Murakami, T., Nihei, R., Ueda, T., Kunikata, H., Jujo, T., Terasaki, H., Nagasato, D., Noda, K., Osaka, R., Nagai, K., ... Inatani, M. (2022). Impact of the COVID-19 Pandemic on Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Japan. Journal of Clinical Medicine, 11(22), 6794. https://doi.org/10.3390/jcm11226794